Metagenomi, Inc. (MGX)
(Delayed Data from NSDQ)
$4.08 USD
+0.31 (8.22%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $4.13 +0.05 (1.23%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for Metagenomi, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -68.26 | -43.59 | -21.44 | NA | NA |
Depreciation/Amortization & Depletion | -5.01 | 0.29 | 0.59 | NA | NA |
Net Change from Assets/Liabilities | -26.43 | 69.49 | 46.26 | NA | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | NA | NA |
Other Operating Activities | 8.28 | 3.54 | -1.15 | NA | NA |
Net Cash From Operating Activities | -91.41 | 29.72 | 24.26 | NA | NA |
Property & Equipment | -9.81 | -13.98 | -2.90 | NA | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | NA | NA |
Investments | 55.55 | -108.22 | -71.41 | NA | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | NA | NA |
Net Cash from Investing Activities | 45.73 | -122.20 | -74.32 | NA | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.30 | 239.59 | 9.95 | NA | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 29.97 | NA | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | NA | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | NA | NA |
Other Financing Activities | -3.28 | 0.00 | 0.00 | NA | NA |
Net Cash from Financing Activities | 1.01 | 239.59 | 39.92 | NA | NA |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | NA | NA |
Net Change In Cash & Equivalents | -44.66 | 147.12 | -10.14 | NA | NA |
Cash at Beginning of Period | 190.51 | 43.40 | 53.53 | NA | NA |
Cash at End of Period | 145.85 | 190.51 | 43.40 | NA | NA |
Diluted Net EPS | -20.05 | -12.82 | NA | NA | NA |
Fiscal Year End for Metagenomi, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -25.15 | -68.26 | NA | NA | -16.13 |
Depreciation/Amortization & Depletion | 0.02 | -5.01 | NA | NA | -1.39 |
Net Change from Assets/Liabilities | -10.91 | -26.43 | NA | NA | -4.98 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | NA | NA | 0.00 |
Other Operating Activities | 6.19 | 8.28 | NA | NA | 1.51 |
Net Cash From Operating Activities | -29.85 | -91.41 | NA | NA | -21.00 |
Property & Equipment | -0.92 | -9.81 | NA | NA | -2.67 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | NA | NA | 0.00 |
Investments | -93.82 | 55.55 | NA | NA | -69.40 |
Other Investing Activities | 0.00 | 0.00 | NA | NA | 0.00 |
Net Cash from Investing Activities | -94.73 | 45.73 | NA | NA | -72.07 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 86.54 | 4.30 | NA | NA | 4.30 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | NA | NA | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | NA | NA | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | NA | NA | 0.00 |
Other Financing Activities | 0.00 | -3.28 | NA | NA | 0.00 |
Net Cash from Financing Activities | 86.54 | 1.01 | NA | NA | 4.30 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | NA | NA | 0.00 |
Net Change In Cash & Equivalents | -38.05 | -44.66 | NA | NA | -88.77 |
Cash at Beginning of Period | 145.85 | 190.51 | NA | NA | 190.51 |
Cash at End of Period | 107.81 | 145.85 | NA | NA | 101.75 |
Diluted Net EPS | -1.19 | NA | NA | NA | NA |